Nagendra K Chaturvedi (Nagendra Chaturvedi)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 16

Top Topics

Transcription Factor

Top Venues

Journal of experimental & clinical cancer research : CR

Cell death & disease

This page only lists publications with an associated author ORCID identifier.

Publications

Don W Coulter, Yashpal S Chhonker, Devendra Kumar, Varun Kesherwani, Wafaa N Aldhafiri, Erin M McIntyre, Gracey Alexander, Sutapa Ray, Shantaram S Joshi, Rongshi Li, Daryl J Murry, Nagendra K Chaturvedi
Marinopyrrole derivative MP1 as a novel anti-cancer agent in group 3 MYC-amplified Medulloblastoma. Journal of experimental & clinical cancer research : CR 43 (1) (2024)
Don W Coulter, Yashpal S Chhonker, Devendra Kumar, Varun Kesherwani, Wafaa N Aldhafiri, Erin M McIntyre, Gracey Alexander, Sutapa Ray, Shantaram S Joshi, Rongshi Li, Daryl J Murry, Nagendra K Chaturvedi
Marinopyrrole derivative MP1 as a novel anti-cancer agent in group 3 MYC-amplified Medulloblastoma. Journal of experimental & clinical cancer research : CR 43 (1) (2024)
Don W Coulter, Yashpal S Chhonker, Devendra Kumar, Varun Kesherwani, Wafaa N Aldhafiri, Erin M McIntyre, Gracey Alexander, Sutapa Ray, Shantaram S Joshi, Rongshi Li, Daryl J Murry, Nagendra K Chaturvedi
Marinopyrrole derivative MP1 as a novel anti-cancer agent in group 3 MYC-amplified Medulloblastoma. Journal of experimental & clinical cancer research : CR 43 (1) (2024)
Anup Singh Pathania, Haritha Chava, Nagendra K Chaturvedi, Srinivas Chava, Siddappa N Byrareddy, Don W Coulter, Kishore B Challagundla
The miR-29 family facilitates the activation of NK-cell immune responses by targeting the B7-H3 immune checkpoint in neuroblastoma. Cell death & disease 15 (6) (2024)
Anup Singh Pathania, Haritha Chava, Nagendra K Chaturvedi, Srinivas Chava, Siddappa N Byrareddy, Don W Coulter, Kishore B Challagundla
The miR-29 family facilitates the activation of NK-cell immune responses by targeting the B7-H3 immune checkpoint in neuroblastoma. Cell death & disease 15 (6) (2024)
Anup Singh Pathania, Haritha Chava, Nagendra K Chaturvedi, Srinivas Chava, Siddappa N Byrareddy, Don W Coulter, Kishore B Challagundla
The miR-29 family facilitates the activation of NK-cell immune responses by targeting the B7-H3 immune checkpoint in neuroblastoma. Cell death & disease 15 (6) (2024)
Devendra Kumar, Stuti Jain, Donald W Coulter, Shantaram S Joshi, Nagendra K Chaturvedi
PRMT5 as a Potential Therapeutic Target in MYC-Amplified Medulloblastoma. Cancers 15 (24) (2023)
Devendra Kumar, Stuti Jain, Donald W Coulter, Shantaram S Joshi, Nagendra K Chaturvedi
PRMT5 as a Potential Therapeutic Target in MYC-Amplified Medulloblastoma. Cancers 15 (24) (2023)
Kyle A Rohrer, Heyu Song, Anum Akbar, Yingling Chen, Suravi Pramanik, Phillip J Wilder, Erin M McIntyre, Nagendra K Chaturvedi, Kishor K Bhakat, Angie Rizzino, Donald W Coulter, Sutapa Ray
STAT3 Inhibition Attenuates MYC Expression by Modulating Co-Activator Recruitment and Suppresses Medulloblastoma Tumor Growth by Augmenting Cisplatin Efficacy In Vivo. Cancers 15 (8) (2023)
Kyle A Rohrer, Heyu Song, Anum Akbar, Yingling Chen, Suravi Pramanik, Phillip J Wilder, Erin M McIntyre, Nagendra K Chaturvedi, Kishor K Bhakat, Angie Rizzino, Donald W Coulter, Sutapa Ray
STAT3 Inhibition Attenuates MYC Expression by Modulating Co-Activator Recruitment and Suppresses Medulloblastoma Tumor Growth by Augmenting Cisplatin Efficacy In Vivo. Cancers 15 (8) (2023)
Sukanya Chakraborty, Aaqib M Bhat, Insha Mushtaq, Haitao Luan, Achyuth Kalluchi, Sameer Mirza, Matthew D Storck, Nagendra K Chaturvedi, Jose Antonio Lopez-Guerrero, Antonio Llombart-Bosch, Isidro Machado, Katia Scotlandi, Jane L Meza, Gargi Ghosal, Donald W Coulter, M Jordan Rowley, Vimla Band, Bhopal C Mohapatra, Hamid Band
EHD1-dependent traffic of IGF-1 receptor to the cell surface is essential for Ewing sarcoma tumorigenesis and metastasis. Communications biology 6 (1) (2023)
Matthew J Kling, Varun Kesherwani, Nitish K Mishra, Gracey Alexander, Erin M McIntyre, Sutapa Ray, Kishore B Challagundla, Shantaram S Joshi, Don W Coulter, Nagendra K Chaturvedi
A novel dual epigenetic approach targeting BET proteins and HDACs in Group 3 (MYC-driven) Medulloblastoma. Journal of experimental & clinical cancer research : CR 41 (1) (2022)
Sutapa Ray, Nagendra K Chaturvedi, Kishor K Bhakat, Angie Rizzino, Sidharth Mahapatra
Subgroup-Specific Diagnostic, Prognostic, and Predictive Markers Influencing Pediatric Medulloblastoma Treatment. Diagnostics (Basel, Switzerland) 12 (1) (2021)
Matthew J Kling, Connor N Griggs, Erin M McIntyre, Gracey Alexander, Sutapa Ray, Kishore B Challagundla, Shantaram S Joshi, Don W Coulter, Nagendra K Chaturvedi
Synergistic efficacy of inhibiting MYCN and mTOR signaling against neuroblastoma. BMC cancer 21 (1) (2021)
Nagendra K Chaturvedi, Matthew J Kling, Connor N Griggs, Varun Kesherwani, Mamta Shukla, Erin M McIntyre, Sutapa Ray, Yutong Liu, Timothy R McGuire, J Graham Sharp, Hamid Band, Shantaram S Joshi, Don W Coulter
A Novel Combination Approach Targeting an Enhanced Protein Synthesis Pathway in MYC-driven (Group 3) Medulloblastoma. Molecular cancer therapeutics 19 (6) (2020)
Nagendra K Chaturvedi, Sidharth Mahapatra, Varun Kesherwani, Matthew J Kling, Mamta Shukla, Sutapa Ray, Ranjana Kanchan, Naveenkumar Perumal, Timothy R McGuire, J Graham Sharp, Shantaram S Joshi, Don W Coulter
Role of protein arginine methyltransferase 5 in group 3 (MYC-driven) Medulloblastoma. BMC cancer 19 (1) (2019)